AliveCor suffers another loss in Apple Watch ECG patent battle

The U.S. Customs have found that the redesigned ECG in Apple Watch doesn't violate AliveCor patents, thus making AliveCor's legal battles even more challenging.Apple Watch Series 9Apple is tangled in multiple lawsuits around Apple Watch technologies. While Masimo succeeded in getting an import ban, which Apple bypassed, AliveCor isn't having any luck in court.According to a filing from the U.S. Customs and Border Protection (CBP), Apple isn't violating any AliveCor patents in Apple Watch models with redesigned ECGs. Therefore, those models are not under the International Trade Commission's (ITC) Limited Exclusion Order (LEO). Continue Reading on AppleInsider | Discuss on our Forums